GBT
MEDP icon

Grove Bank & Trust’s Medpace MEDP Stock Holding History

Grove Bank & Trust’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.24K Hold
8
– – ﹤0.01% 747
2026
Q1 		$3.84K Hold
8
– – ﹤0.01% 739
2025
Q4 		$4.49K Hold
8
– – ﹤0.01% 738
2025
Q3 		$4.11K Hold
8
– – ﹤0.01% 731
2025
Q2 		$2.51K Sell
8
-19
-70% -$5.7K ﹤0.01% 768
2025
Q1 		$8.23K Buy
27
+18
+200% +$6.05K ﹤0.01% 611
2024
Q4 		$2.99K Buy
+9
New +$3.05K ﹤0.01% 657

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Grove Bank & Trust's MEDP Position: Q2 2026 in Review

Grove Bank & Trust held its Medpace (MEDP) position steady in Q2 2026 at 8 shares worth $4.24K. The position accounts for ﹤0.01% of the portfolio, ranked #747.

Grove Bank & Trust first reported a position in MEDP in Q4 2024 and has held it in 7 quarters since. The position peaked at $8.23K in Q1 2025. 694 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Grove Bank & Trust held 8 shares of Medpace worth $4.24K as of Q2 2026.
  • Grove Bank & Trust left its Medpace share count unchanged in Q2 2026.
  • Medpace made up ﹤0.01% of Grove Bank & Trust's portfolio in Q2 2026, its #747 holding.
  • Grove Bank & Trust first reported a position in Medpace in Q4 2024 and has held it in 7 quarters since.
  • Grove Bank & Trust's Medpace position peaked at $8.23K in Q1 2025.
  • 694 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Grove Bank & Trust's 13F filing for Q2 2026, filed 7 Jul 2026.